These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1505154)
1. The relationship between alfentanil distribution kinetics and cardiac output. Henthorn TK; Krejcie TC; Avram MJ Clin Pharmacol Ther; 1992 Aug; 52(2):190-6. PubMed ID: 1505154 [TBL] [Abstract][Full Text] [Related]
2. Recirculatory and compartmental pharmacokinetic modeling of alfentanil in pigs: the influence of cardiac output. Kuipers JA; Boer F; Olofsen E; Olieman W; Vletter AA; Burm AG; Bovill JG Anesthesiology; 1999 Apr; 90(4):1146-57. PubMed ID: 10201688 [TBL] [Abstract][Full Text] [Related]
3. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution. Avram MJ; Krejcie TC; Henthorn TK; Niemann CU J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245 [TBL] [Abstract][Full Text] [Related]
4. Alfentanil clearance is independent of the polymorphic debrisoquin hydroxylase. Henthorn TK; Avram MJ; Krejcie TC Anesthesiology; 1989 Nov; 71(5):635-9. PubMed ID: 2817455 [TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics and locomotor activity of alfentanil in the horse. Pascoe PJ; Black WD; Claxton JM; Sansom RE J Vet Pharmacol Ther; 1991 Sep; 14(3):317-25. PubMed ID: 1744940 [TBL] [Abstract][Full Text] [Related]
6. Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients. Björkman S; Wada DR; Stanski DR Anesthesiology; 1998 Mar; 88(3):657-67. PubMed ID: 9523809 [TBL] [Abstract][Full Text] [Related]
7. Single-point sampling for assessment of constitutive, induced, and inhibited cytochrome P450 3A activity with alfentanil or midazolam. Chaobal HN; Kharasch ED Clin Pharmacol Ther; 2005 Nov; 78(5):529-39. PubMed ID: 16321619 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of alfentanil before and after cardiopulmonary bypass in pigs: Part II. den Hollander JM; Burm AG; Vletter AA; Bovill JG J Cardiothorac Vasc Anesth; 1992 Jun; 6(3):313-5. PubMed ID: 1610997 [TBL] [Abstract][Full Text] [Related]
9. Indocyanine green kinetics characterize blood volume and flow distribution and their alteration by propranolol. Niemann CU; Henthorn TK; Krejcie TC; Shanks CA; Enders-Klein C; Avram MJ Clin Pharmacol Ther; 2000 Apr; 67(4):342-50. PubMed ID: 10801242 [TBL] [Abstract][Full Text] [Related]
10. Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis. Baririan N; Van Obbergh L; Desager JP; Verbeeck RK; Wallemacq P; Starkel P; Horsmans Y Clin Pharmacokinet; 2007; 46(3):261-70. PubMed ID: 17328584 [TBL] [Abstract][Full Text] [Related]
11. Use of parallel Erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs. Krejcie TC; Jacquez JA; Avram MJ; Niemann CU; Shanks CA; Henthorn TK J Pharmacokinet Biopharm; 1996 Dec; 24(6):569-88. PubMed ID: 9300351 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of alfentanil administered at a variable rate during three types of surgery. Burm AG; Ausems ME; Spierdijk J; Stanski DR Eur J Anaesthesiol; 1993 Jul; 10(4):241-51. PubMed ID: 8330593 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of alfentanil in man. Camu F; Gepts E; Rucquoi M; Heykants J Anesth Analg; 1982 Aug; 61(8):657-61. PubMed ID: 6124179 [TBL] [Abstract][Full Text] [Related]
14. Minimal compartmental model of circulatory mixing of indocyanine green. Henthorn TK; Avram MJ; Krejcie TC; Shanks CA; Asada A; Kaczynski DA Am J Physiol; 1992 Mar; 262(3 Pt 2):H903-10. PubMed ID: 1558199 [TBL] [Abstract][Full Text] [Related]
15. [Effect of duration of infusion on elimination rate of alfentanil]. Castor G; Altmayer P; Venitz J Anaesthesiol Reanim; 1995; 20(4):97-100. PubMed ID: 7575958 [TBL] [Abstract][Full Text] [Related]